Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term

03.12.25 15:50 Uhr

Werte in diesem Artikel
Aktien

155,80 EUR -0,85 EUR -0,54%

Indizes

9.692,1 PKT -9,7 PKT -0,10%

5.223,5 PKT -4,1 PKT -0,08%

9.435,5 PKT 37,6 PKT 0,40%

2.399,0 PKT -5,0 PKT -0,21%

2.783,5 PKT -1,0 PKT -0,04%

1.016,4 PKT -3,1 PKT -0,30%

4.807,8 PKT 5,1 PKT 0,11%

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.The Style Scores are broken down into four categories:Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum. How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.93% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.That's where the Style Scores come in.To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.Stock to Watch: Astrazeneca (AZN)AstraZeneca plc, headquartered in London, UK, is one of the largest biopharmaceutical companies in the world. AstraZeneca was formed on Apr 6, 1999, through the merger of Sweden’s Astra AB and UK’s Zeneca Group plc. AstraZeneca’s business can be broken down into separate lines based on therapeutic classes. These include CVRM (cardiovascular, renal and metabolism), Respiratory & Immunology (R&I), Oncology, Rare Diseases, Vaccines and Other.AZN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.Momentum investors should take note of this Medical stock. AZN has a Momentum Style Score of A, and shares are up 9.9% over the past four weeks.Four analysts revised their earnings estimate higher in the last 60 days for fiscal 2025, while the Zacks Consensus Estimate has increased $0.05 to $4.61 per share. AZN also boasts an average earnings surprise of +3.8%.With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, AZN should be on investors' short list.Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AstraZeneca PLC (AZN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf AstraZeneca

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf AstraZeneca

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu AstraZeneca PLC

Wer­bung

Analysen zu AstraZeneca PLC

DatumRatingAnalyst
01.12.2025AstraZeneca BuyJefferies & Company Inc.
25.11.2025AstraZeneca SellDeutsche Bank AG
14.11.2025AstraZeneca OutperformBernstein Research
12.11.2025AstraZeneca SellDeutsche Bank AG
10.11.2025AstraZeneca HaltenDZ BANK
DatumRatingAnalyst
01.12.2025AstraZeneca BuyJefferies & Company Inc.
14.11.2025AstraZeneca OutperformBernstein Research
10.11.2025AstraZeneca OutperformBernstein Research
10.11.2025AstraZeneca OverweightJP Morgan Chase & Co.
07.11.2025AstraZeneca BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
10.11.2025AstraZeneca HaltenDZ BANK
18.09.2025AstraZeneca HoldDeutsche Bank AG
17.09.2025AstraZeneca HoldDeutsche Bank AG
08.09.2025AstraZeneca HoldDeutsche Bank AG
01.09.2025AstraZeneca HoldDeutsche Bank AG
DatumRatingAnalyst
25.11.2025AstraZeneca SellDeutsche Bank AG
12.11.2025AstraZeneca SellDeutsche Bank AG
07.11.2025AstraZeneca SellDeutsche Bank AG
22.10.2025AstraZeneca SellDeutsche Bank AG
16.10.2025AstraZeneca SellDeutsche Bank AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für AstraZeneca PLC nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen